Table of contents
Volume 79, Issue 7-8
Published online 12 February 1999 (1005-1318)
Regular Articles
Inactivation of the transforming growth factor 
type II receptor in human small cell lung cancer cell lines FREE
S Hougaard, P Nørgaard, N Abrahamsen, H L Moses, M Spang-Thomsen and H Skovgaard Poulsen
Br J Cancer 79: 1005-1011; doi:10.1038/sj.bjc.6690161
Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer FREE
N Benachenhou, S Guiral, I Gorska-Flipot, D Labuda and D Sinnett
Br J Cancer 79: 1012-1017; doi:10.1038/sj.bjc.6690162
Butyrate augments interferon-
-induced S phase accumulation and persistent tyrosine phosphorylation of cdc2 in K562 cells FREE
T Miyachi, M Adachi, Y Hinoda and K Imai
Br J Cancer 79: 1018-1024; doi:10.1038/sj.bjc.6690163
The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice FREE
U Mrowietz, U Schwenk, S Maune, J Bartels, M Küpper, I Fichtner, J-M Schröder and D Schadendorf
Br J Cancer 79: 1025-1031; doi:10.1038/sj.bjc.6690164
Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells FREE
M Urashima, G Teoh, M Akiyama, Y Yuza, K C Anderson and K Maekawa
Br J Cancer 79: 1032-1036; doi:10.1038/sj.bjc.6690165
Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts FREE
U Kasten, N Plottner, J Johansen, J Overgaard and E Dikomey
Br J Cancer 79: 1037-1041; doi:10.1038/sj.bjc.6690166
Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia FREE
B Bauvois, I De Meester, J Dumont, D Rouillard, H X Zhao and E Bosmans
Br J Cancer 79: 1042-1048; doi:10.1038/sj.bjc.6690167
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3 FREE
A-M Cleton-Jansen, E W Moerland, J C Pronk, C G M van Berkel, S Apostolou, J Crawford, A Savoia, A D Auerbach, C G Mathew, D F Callen and C J Cornelisse
Br J Cancer 79: 1049-1052; doi:10.1038/sj.bjc.6690168
Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918 FREE
A Wallstab, M Koester, M Böhme and D Keppler
Br J Cancer 79: 1053-1060; doi:10.1038/sj.bjc.6690169
Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts FREE
H-B Ris, T Krueger, A Giger, C K Lim, J C M Stewart, U Althaus and H J Altermatt
Br J Cancer 79: 1061-1066; doi:10.1038/sj.bjc.6690170
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases FREE
L Quintieri, A Rosato, N Amboldi, C Vizler, D Ballinari, P Zanovello and D Collavo
Br J Cancer 79: 1067-1073; doi:10.1038/sj.bjc.6690171
In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data FREE
B Stausbøl-Grøn, S M Bentzen, K E Jørgensen, O S Nielsen, T Bundgaard and J Overgaard
Br J Cancer 79: 1074-1084; doi:10.1038/sj.bjc.6690172
Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation FREE
M Y Janssens, V N Verovski, D L Van den Berge, C Monsaert and G A Storme
Br J Cancer 79: 1085-1089; doi:10.1038/sj.bjc.6690173
Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells FREE
M-G Côme, A Skladanowski, A K Larsen and G Laurent
Br J Cancer 79: 1090-1097; doi:10.1038/sj.bjc.6690174
Inhibition of transforming growth factor (TGF-)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868 FREE
B J B Simpson, J M S Bartlett, K G Macleod, G Rabiasz, E P Miller, A L Rae, P Gordge, R E Leake, W R Miller, J Smyth and S P Langdon
Br J Cancer 79: 1098-1103; doi:10.1038/sj.bjc.6690175
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells FREE
A Nehmé, R Baskaran, S Nebel, D Fink, S B Howell, J Y J Wang and R D Christen
Br J Cancer 79: 1104-1110; doi:10.1038/sj.bjc.6690176
Human thyroid cancer cells as a source of iso-genic, iso-phenotypic cell lines with or without functional p53 FREE
F S Wyllie, M F Haughton, J M Rowson and D Wynford-Thomas
Br J Cancer 79: 1111-1120; doi:10.1038/sj.bjc.6690177
Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice FREE
Y Doki, K Murakami, T Yamaura, S Sugiyama, T Misaki and I Saiki
Br J Cancer 79: 1121-1126; doi:10.1038/sj.bjc.6690178
Expression of CD3-
on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes FREE
T D de Gruijl, H J Bontkes, F Peccatori, M P W Gallee, Th J M Helmerhorst, R H M Verheijen, J Aarbiou, W M C Mulder, J M M Walboomers, C J L M Meijer, N van de Vange and R J Scheper
Br J Cancer 79: 1127-1132; doi:10.1038/sj.bjc.6690179
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate FREE
L P Setälä, M I Tammi, R H Tammi, M J Eskelinen, P K Lipponen, U M Ågren, J Parkkinen, E M Alhava and V-M Kosma
Br J Cancer 79: 1133-1138; doi:10.1038/sj.bjc.6690180
Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations FREE
S Nakagawa, H Yoshikawa, H Jimbo, T Onda, T Yasugi, K Matsumoto, N Kino, K Kawana, T Kozuka, K Nakagawa, M Aoki and Y Taketani
Br J Cancer 79: 1139-1144; doi:10.1038/sj.bjc.6690181
Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer FREE
T Yoshikawa, K Suzuki, O Kobayashi, M Sairenji, H Motohashi, A Tsuburaya, Y Nakamura, A Shimizu, S Yanoma and Y Noguchi
Br J Cancer 79: 1145-1150; doi:10.1038/sj.bjc.6690182
Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia FREE
Y-M Zhu, L Foroni, I G McQuaker, M Papaioannou, A Haynes and H H Russell
Br J Cancer 79: 1151-1157; doi:10.1038/sj.bjc.6690183
Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer FREE
J M M Terwogt, I A M Mandjes, H Sindermann, J H Beijnen and W W ten Bokkel Huinink
Br J Cancer 79: 1158-1161; doi:10.1038/sj.bjc.6690184
The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients FREE
E Reyes, J Carballido, L Manzano, L Moltó, C Olivier and M Alvarez-Mon
Br J Cancer 79: 1162-1167; doi:10.1038/sj.bjc.6690185
Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma FREE
S Uchida, Y Shimada, G Watanabe, Z Gang Li, T Hong, M Miyake and M Imamura
Br J Cancer 79: 1168-1173; doi:10.1038/sj.bjc.6690186
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma FREE
M P Michelagnoli, I J Lewis, H R Gattamaneni, C C Bailey and L S Lashford
Br J Cancer 79: 1174-1178; doi:10.1038/sj.bjc.6690187
A high incidence of vertebral fracture in women with breast cancer FREE
J A Kanis, E V McCloskey, T Powles, A H G Paterson, S Ashley and T Spector
Br J Cancer 79: 1179-1181; doi:10.1038/sj.bjc.6690188
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma FREE
F Wittke, R Hoffmann, J Buer, I Dallmann, K Oevermann, S Sel, T Wandert, A Ganser and J Atzpodien
Br J Cancer 79: 1182-1184; doi:10.1038/sj.bjc.6690189
Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis FREE
A Abudu, D C Mangham, G M Reynolds, P B Pynsent, R M Tillman, S R Carter and R J Grimer
Br J Cancer 79: 1185-1189; doi:10.1038/sj.bjc.6690190
Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients FREE
J H de Witte, C G J Sweep, J G M Klijn, N Grebenschikov, H A Peters, M P Look, Th H van Tienoven, J J T M Heuvel, W L J van Putten, Th J Benraad and J A Foekens
Br J Cancer 79: 1190-1198; doi:10.1038/sj.bjc.6690191
Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience FREE
E Bouffet, M C Baranzelli, C Patte, M Portas, C Edan, P Chastagner, F Mechinaud-Lacroix, C Kalifa and on behalf of the Société Française d'Oncologie Pédiatrique
Br J Cancer 79: 1199-1204; doi:10.1038/sj.bjc.6690192
Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma FREE
P Gustafson, B Baldetorp, M Fernö and M Åkerman
Br J Cancer 79: 1205-1209; doi:10.1038/sj.bjc.6690193
European randomized study of prostate cancer screening: first-year results of the Finnish trial FREE
L Määttänen, A Auvinen, U-H Stenman, S Rannikko, T Tammela, J Aro, H Juusela and M Hakama
Br J Cancer 79: 1210-1214; doi:10.1038/sj.bjc.6690194
Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies FREE
F M Laurencet, G B Zulian, M Guetty-Alberto, P A Iten, D C Betticher and P Alberto
Br J Cancer 79: 1215-1219; doi:10.1038/sj.bjc.6690195
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer FREE
S J Houston, T A Plunkett, D M Barnes, P Smith, R D Rubens and D W Miles
Br J Cancer 79: 1220-1226; doi:10.1038/sj.bjc.6690196
Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation FREE
E Grunfeld, A Gray, D Mant, P Yudkin, R Adewuyi-Dalton, D Coyle, D Cole, J Stewart, R Fitzpatrick and M Vessey
Br J Cancer 79: 1227-1233; doi:10.1038/sj.bjc.6690197
Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma FREE
Y Shi, R S Parhar, M Zou, M M Hammami, M Akhtar, Z-P Lum, N R Farid, S T Al-Sedairy and M C Paterson
Br J Cancer 79: 1234-1239; doi:10.1038/sj.bjc.6690198
The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBP during epithelial tumour progression FREE
K Sundfeldt, K Ivarsson, M Carlsson, S Enerbäck, P O Janson, M Brännström and L Hedin
Br J Cancer 79: 1240-1248; doi:10.1038/sj.bjc.6690199
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers FREE
J Fujimoto, H Sakaguchi, R Hirose, S Ichigo and T Tamaya
Br J Cancer 79: 1249-1254; doi:10.1038/sj.bjc.6690200
Prognostic value of p53 protein expression for patients with gastric cancer – a multivariate analysis FREE
Y Maehara, M Tomoda, S Hasuda, A Kabashima, E Tokunaga, Y Kakeji and K Sugimachi
Br J Cancer 79: 1255-1261; doi:10.1038/sj.bjc.6690201
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas FREE
B Mann, A Gratchev, C Böhm, M L Hanski, H D Foss, G Demel, B Trojanek, I Schmidt-Wolf, H Stein, E O Riecken, H J Buhr and C Hanski
Br J Cancer 79: 1262-1269; doi:10.1038/sj.bjc.6690202
Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role? FREE
A M Gillespie, N Siddiqui, R E Coleman and B W Hancock
Br J Cancer 79: 1270-1272; doi:10.1038/sj.bjc.6690203
Is sunlight an aetiological agent in the genesis of retinoblastoma? FREE
M L Hooper
Br J Cancer 79: 1273-1276; doi:10.1038/sj.bjc.6690204
Cancer mortality in East and Southeast Asian migrants to New South Wales, Australia, 1975–1995 FREE
M McCredie, S Williams and M Coates
Br J Cancer 79: 1277-1282; doi:10.1038/sj.bjc.6690205
Food groups and colorectal cancer risk FREE
F Levi, C Pasche, C La Vecchia, F Lucchini and S Franceschi
Br J Cancer 79: 1283-1287; doi:10.1038/sj.bjc.6690206
Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels FREE
R Z Omar, J A Barber and P G Smith
Br J Cancer 79: 1288-1301; doi:10.1038/sj.bjc.6690207
Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients FREE
O Díez, A Osorio, M Robledo, A Barroso, M Domènech, J Cortés, J Albertos, J Sanz, J Brunet, J M SanRomán, M C Alonso, M Baiget and J Benítez
Br J Cancer 79: 1302-1303; doi:10.1038/sj.bjc.6690208
Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia FREE
H M Inskip, L J Kinlen, A M R Taylor, C G Woods and C F Arlett
Br J Cancer 79: 1304-1307; doi:10.1038/sj.bjc.6690209
Alcohol consumption and breast cancer oestrogen and progesterone receptor status FREE
S M Enger, R K Ross, A Paganini-Hill, M P Longnecker and L Bernstein
Br J Cancer 79: 1308-1314; doi:10.1038/sj.bjc.6690210
Book Review
Top of pageCalendar
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
